132 related articles for article (PubMed ID: 8821304)
1. Prostaglandin D2 measurement in nasal secretions is not a reliable marker for mast cell activation in atopic patients.
Wang DY; Smitz J; Clement P
Clin Exp Allergy; 1995 Dec; 25(12):1228-34. PubMed ID: 8821304
[TBL] [Abstract][Full Text] [Related]
2. Concentrations of chemical mediators in nasal secretions after nasal allergen challenges in atopic patients.
Wang D; Clement P; Smitz J; Derde MP
Eur Arch Otorhinolaryngol; 1995; 252 Suppl 1():S40-3. PubMed ID: 7734974
[TBL] [Abstract][Full Text] [Related]
3. Unilateral nasal allergen challenge leads to bilateral release of prostaglandin D2.
Wagenmann M; Baroody FM; Desrosiers M; Hubbard WC; Ford S; Lichtenstein LM; Naclerio RM
Clin Exp Allergy; 1996 Apr; 26(4):371-8. PubMed ID: 8732233
[TBL] [Abstract][Full Text] [Related]
4. [Humoral mucosal immunity in allergic rhinitis].
Kramer MF; Jordan TR; Pfrogner E; Rasp G
Laryngorhinootologie; 2005 Jul; 84(7):503-10. PubMed ID: 16010632
[TBL] [Abstract][Full Text] [Related]
5. Correlation between symptoms and the threshold for release of mediators in nasal secretions during nasal challenge with grass-pollen grains.
Lebel B; Bousquet J; Morel A; Chanal I; Godard P; Michel FB
J Allergy Clin Immunol; 1988 Nov; 82(5 Pt 1):869-77. PubMed ID: 2461405
[TBL] [Abstract][Full Text] [Related]
6. On the role of PGD2 metabolites as markers of mast cell activation in asthma.
O'Sullivan S
Acta Physiol Scand Suppl; 1999 Apr; 644():1-74. PubMed ID: 10352758
[TBL] [Abstract][Full Text] [Related]
7. Increased urinary excretion of the prostaglandin D2 metabolite 9 alpha, 11 beta-prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction.
O'Sullivan S; Dahlén B; Dahlén SE; Kumlin M
J Allergy Clin Immunol; 1996 Aug; 98(2):421-32. PubMed ID: 8757220
[TBL] [Abstract][Full Text] [Related]
8. Mediator release after allergic and physical nasal challenges.
Norman PS; Naclerio RM; Creticos PS; Togias A; Lichtenstein LM
Int Arch Allergy Appl Immunol; 1985; 77(1-2):57-63. PubMed ID: 2409027
[TBL] [Abstract][Full Text] [Related]
9. Indirect evidence of nasal inflammation assessed by titration of inflammatory mediators and enumeration of cells in nasal secretions of patients with chronic rhinitis.
Knani J; Campbell A; Enander I; Peterson CG; Michel FB; Bousquet J
J Allergy Clin Immunol; 1992 Dec; 90(6 Pt 1):880-9. PubMed ID: 1334102
[TBL] [Abstract][Full Text] [Related]
10. Release of histamine and leukotriene C4 in immediate allergic wheal reaction as measured with the microdialysis technique.
Saarinen JV; Harvima RJ; Naukkarinen A; Horsmanheimo M; Harvima IT
Arch Dermatol Res; 2000 Jul; 292(7):333-40. PubMed ID: 10966057
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic mechanisms underlying the clinical symptoms of allergic rhinitis.
Wang DY; Clement P
Am J Rhinol; 2000; 14(5):325-33. PubMed ID: 11068658
[TBL] [Abstract][Full Text] [Related]
12. Effect of continuous allergen challenge on clinical symptoms and mediator release in dust-mite-allergic patients.
Horak F; Toth J; Hirschwehr R; Marks B; Stübner UP; Jäger S; Berger U; Schleinzer K; Günczler P
Allergy; 1998 Jan; 53(1):68-72. PubMed ID: 9491231
[TBL] [Abstract][Full Text] [Related]
13. Mast cell inhibitor R112 is well tolerated and affects prostaglandin D2 but not other mediators, symptoms, or nasal volumes in a nasal challenge model of allergic rhinitis.
Guyer BJ; Shimamoto SR; Bradhurst AL; Grossbard EB; Dreskin SC; Nelson HS
Allergy Asthma Proc; 2006; 27(3):208-13. PubMed ID: 16913263
[TBL] [Abstract][Full Text] [Related]
14. The release of prostaglandin D2 from human skin in vivo and in vitro during immediate allergic reactions.
Barr RM; Koro O; Francis DM; Black AK; Numata T; Greaves MW
Br J Pharmacol; 1988 Jul; 94(3):773-80. PubMed ID: 2460180
[TBL] [Abstract][Full Text] [Related]
15. Chronic sinusitis: characterization of cellular influx and inflammatory mediators in sinus lavage fluid.
Georgitis JW; Matthews BL; Stone B
Int Arch Allergy Immunol; 1995 Apr; 106(4):416-21. PubMed ID: 7719157
[TBL] [Abstract][Full Text] [Related]
16. Expression of prostaglandin D synthase and the prostaglandin D2 receptors DP and CRTH2 in human nasal mucosa.
Nantel F; Fong C; Lamontagne S; Wright DH; Giaid A; Desrosiers M; Metters KM; O'Neill GP; Gervais FG
Prostaglandins Other Lipid Mediat; 2004 Jan; 73(1-2):87-101. PubMed ID: 15165034
[TBL] [Abstract][Full Text] [Related]
17. Role of prostaglandin D2 and CRTH2 blockade in early- and late-phase nasal responses.
Shiraishi Y; Takeda K; Domenico J; Gelfand EW
Clin Exp Allergy; 2014 Aug; 44(8):1076-82. PubMed ID: 24456221
[TBL] [Abstract][Full Text] [Related]
18. The pathophysiology of rhinitis. V. Sources of protein in allergen-induced nasal secretions.
Raphael GD; Igarashi Y; White MV; Kaliner MA
J Allergy Clin Immunol; 1991 Jul; 88(1):33-42. PubMed ID: 1712803
[TBL] [Abstract][Full Text] [Related]
19. 9α,11β-PGF2, a Prostaglandin D2 Metabolite, as a Marker of Mast Cell Activation in Bee Venom-Allergic Patients.
Nittner-Marszalska M; Cichocka-Jarosz E; Sanak M; Wujczyk M; Dor-Wojnarowska A; Lis G; Liebhart J
Arch Immunol Ther Exp (Warsz); 2015 Aug; 63(4):317-25. PubMed ID: 25763689
[TBL] [Abstract][Full Text] [Related]
20. Syk-kinase inhibition prevents mast cell activation in nasal polyps.
Patou J; Holtappels G; Affleck K; van Cauwenberge P; Bachert C
Rhinology; 2011 Mar; 49(1):100-6. PubMed ID: 21468383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
